Buprenorphine/Naloxone Micro-Dosing for Postoperative Pain Management in Opioid-Tolerant Patients
Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
A randomized clinical study evaluating the effect of buprenorphine/naloxone (bup/nx)
sublingual film on postoperative pain management in opioid-tolerant patients.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone